Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink. [PDF]
Vaccine X, 2023 Hanson KE +11 more
europepmc +1 more source
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. [PDF]
Rev Inst Med Trop Sao Paulo, 2023 Randi BA +6 more
europepmc +1 more source
Evaluation rubella susceptibility women aged 25-30 years in the Kharkiv region [PDF]
, 2017 Актуальність проблеми краснухи у вагітних обумовлена появою синдрому вродженої краснухи (СВК), що складає біля 10 % від загального числа вроджених аномалій.
Семеренська, Т.І.
core
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]
Oman Med J, 2022 Al-Mendalawi MD.
europepmc +1 more source
EPI Update, March 25, 2011 [PDF]
, 2011 Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core
Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study. [PDF]
Cureus, 2023 Surani AS, Un R, Marfatia Y.
europepmc +1 more source
A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants. [PDF]
Contemp Clin Trials Commun, 2023 Thuluva S +7 more
europepmc +1 more source
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. [PDF]
MMWR Morb Mortal Wkly Rep, 2022 Krow-Lucal E +5 more
europepmc +1 more source
Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]
Sultan Qaboos Univ Med J, 2022 Al-Qassabi AM, Al-Farsi F.
europepmc +1 more source